Following the SNMMI 2026 Annual Meeting in Los Angeles, we continued the discussion in Boston with our Lunch & Learn Meeting.
The focus was on a topic that sits at the heart of preclinical radiopharmaceutical research. At BIOEMTECH, imaging is not just one part of what we do. It is where we have built our expertise.
Our imaging systems are designed around the practical needs of preclinical studies, supporting work with SPECT, PET and optical modalities. Helping researchers generate meaningful data faster, more easily and in a more cost-effective way.
That is why it was especially exciting to share the first data from our 3D SPECT imaging developments. Α new step for our systems and for the way we aim to support radiopharmaceutical researchers.
Thank you to everyone who joined us in Boston and contributed to such a focused and engaging discussion.